Pharmaceutical policy and trans health in SUS
reflections from the 17th National Health Conference
DOI:
https://doi.org/10.9771/peri.v1i24.69633Abstract
Trans people face barriers to healthcare access in Brazil, including difficulties obtaining medications. Social control has contributed to the expansion of LGBTQIAP+ health rights within the Brazilian Unified Health System (SUS). This study presents reflections from research-training activities, based on the first author's participation in the 17th National Health Conference and two preparatory events, analyzing how the themes “Trans Health” and “Pharmaceutical Services” were addressed. Among 39 proposals related to the LGBTQIAPN+ population, 94.9% included trans people. Key demands concerned the update of the PNSILGBT, reform of the SUS Transsexual Process, expansion of access to hormones, and qualification of health services and professionals. Reflections highlight the relevance of integrated public policies, strengthening pharmaceutical services, and social participation in ensuring equity and comprehensiveness in healthcare.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Livia de Souza Goncalves, Norberto Rech Bonetti, Silvana Nair Leite Contezini, Marina Raijche Mattozo Rover, Filipe Carvalho Matheus, Mareni Rocha Farias, Luciano Soares

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution Noncommercial License that allows the work to be shared with acknowledgment of authorship and initial publication in this journal, but prohibits commercial use.
Authors are authorized to enter into separate additional contracts for non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are permitted and encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal website) at any point before or during the editorial process, as this can generate productive changes and increase the impact and citation of the published work (see The Effect of Open Access).






